MedTrace Logo

A Single Ascending Study of IOP Injection in Patients With Iron Deficient Anemia

NCT03485053 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 49

Last updated 2021-10-28

No results posted yet for this study

Summary

The purpose is to evaluate the efficacy and safety of IOP Injection (MPB-1514) for the treatment of iron-deficient anemia (IDA).

Conditions

Interventions

DRUG

IOP Injection / MPB-1514

Dilute with 5% Dextrose solution (D5W)

Sponsors & Collaborators

  • MegaPro Biomedical Co. Ltd.

    lead INDUSTRY

Principal Investigators

  • Steven Fishbane, MD · North Shore University Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-11-29
Primary Completion
2020-09-30
Completion
2021-08-31
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03485053 on ClinicalTrials.gov